We have spent many years harnessing the power of the human immune system to translate key clinical information about the body’s response to infection rapidly and reliably. Using proprietary biomarkers and existing PCR technology, OrthoDx has developed Synvichor, a world-first genomic PCR test that is able to differentiate between infectious and non-infectious joint pain in a matter of hours using a sample of synovial fluid.
Antony developed Synvichor based on the results of the ELIJA clinical trials across Australia. Previously, he was involved in the successful development and commercialisation of SeptiCyte™ technology for Immunexpress in Seattle USA.
Antony is a medical doctor who spent 5 years training in orthopaedic surgery in Australia and is a PhD candidate in molecular genomics.
Chief Executive Officer and Founder
Chief Operating Officer
Dmitry is a scientific innovator and business strategist with more than two decades of experience in molecular diagnostics and biotechnology. With a background in Molecular Diagnostics, Strategic Management, and a degree in Medicine, he combines scientific expertise with a deep understanding of clinical practice and patient needs.
As Chief Technology Officer at OrthoDx, Dr Kuevda leads the development of next-generation diagnostic technologies.
Chief Technology Officer
Robbie leads the company’s global supply chain strategy, overseeing procurement, logistics, inventory & supplier management. With extensive experience across the diagnostics & medical technology sectors, Robbie focuses on building scalable and resilient supply chains that support OrthoDx’s commercial growth & international expansion.
Working closely with operational, quality, regulatory & commercial teams, Robbie ensures supply chain activities remain aligned with OrthoDx’s strategic objectives while driving efficiency, managing risk & developing strong strategic supplier partnerships.
Chief Supply Chain Officer
Paula is a regulatory affairs and quality assurance leader with more than a decade of experience in the medical device and diagnostics sectors. She combines a strong scientific foundation with strategic regulatory expertise to support the delivery of compliant, high-quality healthcare technologies.
Head of Regulatory Affairs and Quality Assurance
Shauna brings several years of recruitment experience to across the diagnostics and medical technology sectors, with a strong focus on identifying and attracting exceptional talent to support OrthoDx’s continued growth.
She is passionate about connecting talented professionals with opportunities where they can make a meaningful contribution and support OrthoDx’s mission to drive innovation and advancement within healthcare.
Senior Recruitment Consultant
Antony developed Synvichor based on the results of the ELIJA clinical trials across Australia. Previously, he was involved in the successful development and commercialisation of SeptiCyte™ technology for Immunexpress in Seattle USA.
Antony is a medical doctor who spent 5 years training in orthopaedic surgery in Australia and is a PhD candidate in molecular genomics.
Chief Executive Officer and Founder
Michael was the co-founder of Global Orthopaedic Technology and presided over the commercialisation and expansion of the company for 15 years.
Michael is an experienced member of several boards and brings a wealth of experience in commercialising orthopaedic technology to the board at OrthoDx.
Chairman, Commercial Governance Board
Raelene has more than 20 years of experience in providing taxation, accounting and business advisory services to private companies, subsidiaries of multinationals, partnerships and trusts.
Raelene’s strength is in identifying and advising on financial obstacles, to enhance performance and opportunities for business growth.
Chief Financial Officer
Victor is a patent attorney specialising in patent applications in all areas of biotechnology.
With a PhD in biochemistry and molecular biology, postdoctoral experience at the Walter and Eliza Hall Institute of Medical Research and the Queensland Institute of Medical Research, Victor has been instrumental in OrthoDx’s international patent applications for synovial biomarkers.
Advisor
Richard is an orthopaedic surgeon based in Bundaberg, Queensland, specialising in adult joint replacement and paediatric orthopaedic surgery.
He honed his expertise through prestigious Canadian university fellowships where he developed a particular interest in bone and joint infections. Richard also holds an MBA from the Australian Institute of Business and has a keen interest in medical and corporate governance.
Advisor
Andrew is a senior orthopaedic surgeon based in Adelaide, South Australia. He is renowned for his expertise in musculoskeletal health, particularly complex joint replacement and major orthopaedic trauma.
Andrew is also a senior academic, researcher and clinical educator at both Flinders University and the University of Adelaide. He has extensive experience in cutting-edge orthogenomics, technology-supported surgery and complex revision arthroplasty.
Scientific Advisor
Kevin is a senior orthopaedic surgeon based principally in Brisbane, Australia, and recognised internationally for his expertise in the management of complex trauma and orthopaedic implant-related infections.
As an Associate Professor at the University of Queensland, Kevin is dedicated to delivering quality patient care, while also active in ground breaking research of the highest calibre.
Scientific Advisor
Jeffrey is a renowned figure in the field of critical care medicine and infectious diseases. He has actively participated in global health initiatives and has worked tirelessly to improve patient outcomes.
Jeffrey is an Emeritus Professor at the University of Queensland, and long-time researcher in sepsis.
Scientific Advisor
Jonathan is an orthopaedic and trauma surgeon based in Sydney, Australia, best known for his proficiency in treating complex fractures and injuries.
Jonathan is also a Senior clinical lecturer at the University of Sydney and Macquarie University. His work has contributed to the development of innovative surgical techniques and the advancement of patient care.
Scientific Advisor
